Bay 44-4400: Clinical Trials

7 trials of Bay 44-4400, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 unknown. 4 Phase 1, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 32Completed 1, Not yet recruiting 1
Phase 21Unknown 1

Follow Bay 44-4400: new trials by email Literature Review of Bay 44-4400 trials Research Report on Bay 44-4400

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
emodepside (BAY 44-4400), Mebendazole 100 MG, similar placebo to mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 3Not yet recruitingSwiss Tropical & Public Health Institute3152026-11-062026-08-14
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
emodepside (BAY 44-4400), matching placebo of emodepside, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 3CompletedSwiss Tropical & Public Health Institute3152025-11-252026-10-08
A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants
BAY 44-4400 - Soil-transmitted Helminth Infection, Onchocerciasis (River Blindness)
Phase 1CompletedBayer142024-05-072024-09-27
Emodepside Phase II Trial for Treatment of Onchocerciasis
emodepside, matching placebo of emodepside, ivermectin - Onchocerciasis
Phase 2UnknownDrugs for Neglected Diseases5782021-08-302024-03-05
Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
LSF emodepside (BAY 44-4400) or matching placebo - Filariasis
Phase 1CompletedDrugs for Neglected Diseases242017-11-142020-04-15
Relative Bioavailability Study of Emodepside IR-tablets and Solution
Emodepside (BAY 44-4400) - Filariasis
Phase 1CompletedDrugs for Neglected Diseases772017-10-262020-03-09
First in Man Clinical Trial of Emodepside (BAY 44-4400)
emodepside (BAY 44-4400), placebo - Healthy Volunteers
Phase 1CompletedDrugs for Neglected Diseases792015-12-012020-04-13

Conditions studied

Filariasis (4)  ·  Onchocerciasis (3)  ·  Ancylostomiasis (2)  ·  Enterobiasis (2)  ·  Helminthiasis (2)  ·  Hookworm Infections (2)  ·  Neglected Diseases (2)  ·  Nematode Infections (2)  ·  Onchocerciasis, Ocular (2)  ·  Parasitic Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Infectious (2)  ·  Skin Diseases, Parasitic (2)  ·  Trichuriasis (2)  ·  Secernentea Infections (1)

Sponsors

Drugs for Neglected Diseases (4)  ·  Swiss Tropical & Public Health Institute (2)  ·  Bayer (1)

Countries

United Kingdom (3)  ·  Democratic Republic of the Congo (1)  ·  Germany (1)  ·  Ghana (1)  ·  Philippines (1)  ·  Tanzania (1)

Top investigators

Jennifer Keiser, Professor (2)  ·  Frederic Monnot (1)  ·  Jeremy Dennison (1)  ·  Jeremy Dennison, PhD MBChB (1)  ·  Malcolm Boyce, MD, BSc (1)  ·  Said Mohammed Ali, MSc (1)

Results publications

PMID 41121745

NIH funding

2017 (2), 2015 (1), 2023 (1)